Return-path: Envelope-to: sales_marketing@ferozsons-labs.com Delivery-date: Thu, 08 May 2014 05:48:20 -0700 Received: from localhost ([::1]:40094 helo=ld143.inmotionhosting.com) by ld143.inmotionhosting.com with esmtpsa (TLSv1:DHE-RSA-AES256-SHA:256) (Exim 4.82) (envelope-from ) id 1WiNjW-0001Es-LC; Thu, 08 May 2014 05:47:30 -0700 Received: from 182.186.64.140 ([182.186.64.140]) by secure143.inmotionhosting.com (Horde Framework) with HTTP; Thu, 08 May 2014 12:47:30 +0000 Date: Thu, 08 May 2014 12:47:30 +0000 Message-ID: <20140508124730.Horde.ro7TP7QfIvYXp0wjf1pZoQ9@secure143.inmotionhosting.com> From: ishfaq.ahmad@ferozsons-labs.com To: "Dr. Sohail Manzoor" Cc: sales_marketing@ferozsons-labs.com Subject: Re: Breaking news Hep c breakthrough ORAL Product SOVALDI of GILEAD Sciences in Pakistan marketed by Ferozsons labs. References: In-Reply-To: User-Agent: Internet Messaging Program (IMP) H5 (6.1.4) Content-Type: text/plain; charset=UTF-8; format=flowed; DelSp=Yes MIME-Version: 1.0 Content-Disposition: inline Content-Transfer-Encoding: 8bit Respected Sir, I read it and i can't express my good feeling after hearing that we are pioneer and we make history in not only in pakistan also all over asia. I am assure that we will make history and increase our corporate and scientific image all over the pakistan. sir after this addition i am 100% confidant for the improve our company image. Wishing very best of luck. thanks & Regards Ishfaq Ahmad Gill SHR Multan Quoting "Dr. Sohail Manzoor" : > Dear Colleagues > > Ferozsons labs has made a marketing agreement with GILEAD SCIENCES to > launch their BREAKTHROUGH product for hepatitis C in Pakistan > > > Gilead Sciences was founded in 1987 California , USA. Over the past 27 > years, they have grown to become one of the world¹s largest > biopharmaceutical companies, with approximately 6,000 employees across five > continents. - > > > The U.S. Food and Drug Administration approved Sovaldi (sofosbuvir) to > treat chronic hepatitis C virus (HCV) infection on December 6, 2013. > > Sovaldi is the first drug that has demonstrated safety and efficacy to treat > certain types of HCV infection without the need for co-administration of > interferon. a significant shift in the treatment paradigm for some patients > with chronic hepatitis C. > > Sovaldi is a nucleotide analog inhibitor that blocks a specific protein > needed by the hepatitis C virus to replicate. > > High Cure Rates > > The sales trend of SOVALDI in world can make it the best-selling new drug of > all time. > > We are starting its patient name basis imports from today . This will be > promoted by hepatology managers until registered which is in process in > Pakistan. > > The cost of one sovaldi 400 mg tablet is 1000 US $ ( 100000 Rs) in USA but > SAME medicine made at SAME manufacturing plant with Same brand name BY > Gilead sciences will be available through Ferozsons labs Pakistan at cost of > 18 US $ ( 1785 Rs ). We have made a special system for its distribution > too. > > All such partnerships are giving YOU more opportunities to GROW MORE > business with SCIENCE. > > Best wishes for making SOVALDI a BLOCKBUSTER product of Pakistan with TEAM > WORK. > > > > Dr. Sohail Manzoor > Commercial Director > Ferozsons Laboratories Limited. > 5-KM, Sundar Raiwind Road, Raiwnd, > Lahore. > > Cell: +92 302 8229195 > Tel: +92 423 6026702 > Email: sohail.manzoor@ferozsons-labs.com